Lauren Parr
-
Novel compounds open new research avenues for Alzheimer’s disease therapeutics
Two new compounds developed at the Vanderbilt University Warren Center for Neuroscience Drug Discovery will enable research into a protein family with ties to Alzheimer’s disease, setting the stage for the development of a different kind of therapeutic than is currently available. Read MoreFeb. 24, 2026